Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis

被引:16
作者
Cahill, Kevin S. [1 ]
Chi, John H. [1 ]
Day, Art L. [1 ]
Claus, Elizabeth B. [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
Breast cancer; Craniotomy; Laminectomy; Postoperative survival; Spinal fusion; NERVOUS-SYSTEM METASTASES; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; CNS METASTASES; CARCINOMA; TUMORS; TRASTUZUMAB; PREDICTION; RESECTION;
D O I
10.1227/NEU.0b013e31820773b2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Central nervous system (CNS) metastases are a common occurrence in patients with breast cancer and are identified in up to 30% of patients at autopsy. OBJECTIVE: To determine population-based estimates of survival times after surgical intervention for Medicare patients with metastatic breast cancer to the brain and spinal column. METHODS: Female breast cancer patients with metastases to the brain and spinal column and undergoing neurosurgical treatment were identified through the Surveillance, Epidemiology, and End Results-Medicare database. Estimates of survival were calculated with Kaplan-Meier estimation and a Cox proportional hazards model. RESULTS: There were 643 patients who underwent neurosurgical treatment of metastatic disease from 1986 to 2005. Of these patients, 264 underwent cranial surgery and 379 underwent spinal surgery. There were 40 deaths during the postoperative hospital admission for an inpatient postoperative death rate of 6.2%. Inpatient death has declined by approximately 50% for surgeries performed in the most recent decade; however, the 30-day mortality rate of 9.0% has remained constant. The median postoperative survival after cranial surgery was 7.8 months (95% confidence interval, 6.2-9.2), after laminectomy was 9.4 months (95% confidence interval, 6.3-15.7), and after spinal fusion was 15.7 months (95% confidence interval, 11.9-18.5). Survival after spinal fusion has increased by approximately 50% in the recent decade. Patients with increased survival after cranial surgery were younger, had fewer comorbidities, and had longer periods from breast cancer diagnosis to surgery. Patients with increased survival after spinal neurosurgery had lower-grade lesions and longer time periods from breast cancer diagnosis to surgical treatment. CONCLUSION: After surgically treated metastases, one-third of cranial patients and one-half of spinal patients are alive at 1 year. The overall postoperative survival has increased over time only for spinal fusion procedures.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [21] Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis
    Lin, Yuxiang
    Huang, Kaiyan
    Zeng, Qiang
    Zhang, Jie
    Song, Chuangui
    PEERJ, 2020, 8
  • [22] Epidemiology and Survival after Spinal Meningioma Surgery: A Nationwide Population-Based Study
    Jecko, Vincent
    Weller, Joconde
    Houston, Deborah
    Champeaux-Depond, Charles
    ASIAN SPINE JOURNAL, 2022, 16 (06) : 865 - 873
  • [23] Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia
    Youl, Philippa
    Philpot, Shoni
    Moore, Julie
    Morris, Michelle
    Theile, David E.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (01) : 175 - 185
  • [24] Time-trends in survival in young women with breast cancer in a SEER population-based study
    Ademuyiwa, Foluso O.
    Groman, Adrienne
    Hong, Chi-Chen
    Miller, Austin
    Kumar, Shicha
    Levine, Ellis
    Erwin, Deborah
    Ambrosone, Christine
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) : 241 - 248
  • [25] Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
    Liu, Deyue
    Wu, Jiayi
    Lin, Caijin
    Andriani, Lisa
    Ding, Shuning
    Shen, Kunwei
    Zhu, Li
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] Contemporary survival in metastatic bladder cancer patients: A population-based study
    Di Bello, Francesco
    Siech, Carolin
    Jannello, Letizia Maria Ippolita
    de Angelis, Mario
    Penaranda, Natali Rodriguez
    Tian, Zhe
    Goyal, Jordan A.
    Baudo, Andrea
    Ruvolo, Claudia Colla
    Califano, Gianluigi
    Creta, Massimiliano
    Saad, Fred
    Shariat, Shahrokh F.
    Acquati, Pietro
    de Cobelli, Ottavio
    Briganti, Alberto
    Chun, Felix K. H.
    Micali, Salvatore
    Longo, Nicola
    Karakiewicz, Pierre I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (10) : 1762 - 1768
  • [27] The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis
    Wu, San-Gang
    Zhang, Wen-Weng
    Sun, Jia-Yuan
    Li, Feng-Yan
    Lin, Huan-Xin
    Zhou, Juan
    He, Zhen-Yu
    ONCOTARGET, 2017, 8 (40) : 67851 - 67860
  • [28] Breast Cancer Subtypes and Mortality of Breast Cancer Patients With Brain Metastasis at Diagnosis: A Population-Based Study
    He, Dong-Jie
    Yu, De-Quan
    Wang, Qi-Ming
    Yu, Zong-Yan
    Qi, Yu-Hong
    Shao, Qiu-Ju
    Chang, Hao
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [29] Prognostic Factors Associated With Overall Survival in Breast Cancer Patients With Metastatic Spinal Disease
    Soto, Gervith Reyes
    Cacho-Diaza, Bernardo
    Bravo-Reynab, Carlos
    Guerra-Mora, Jose Raul
    Ovalles, Carlos
    Catillo-Rangel, Carlos
    Ramirez, Manuel de Jesus Encarnacion
    Montemurro, Nicola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [30] Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis
    Longacre, Colleen F.
    Neprash, Hannah T.
    Shippee, Nathan D.
    Tuttle, Todd M.
    Virnig, Beth A.
    WOMENS HEALTH REPORTS, 2021, 2 (01): : 1 - 10